Open Access

Glucose, glutamine, lactic acid and α‑ketoglutarate restore metabolic disturbances and atrophic changes 
in energy‑deprived muscle cells

  • Authors:
    • Miu Ikeda
    • Moe Matsumoto
    • Miki Tamura
    • Masaki Kobayashi
    • Kaoruko Iida
  • View Affiliations

  • Published online on: May 12, 2025     https://doi.org/10.3892/mmr.2025.13562
  • Article Number: 197
  • Copyright: © Ikeda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Skeletal muscle atrophy is often triggered by catabolic conditions such as fasting, malnutrition and chronic diseases; however, the efficacy of nutritional supplementation in maintaining muscle mass and preventing muscle atrophy remains controversial. The present study aimed to compare the inhibitory effects of various nutritional substrates on starvation‑induced catabolic changes and muscle cell atrophy. C2C12 muscle cells were starved for up to 24 h in medium lacking serum and main nutrients (glucose, glutamine and pyruvate). To assess the effects of exogenous substrates, the cells were incubated in starvation medium and individually supplemented with each of the following nutrients: Glucose, amino acids, fatty acids, lactate or ketone bodies. The expression of each gene and protein was analyzed by reverse transcription‑quantitative PCR and western blotting, respectively. Mitochondrial activity was determined by MTT assay and cell morphology was observed by immunofluorescence staining. The results revealed that starvation for >3 h suppressed mitochondrial activity, and after 5 h of starvation, the expression levels of several metabolic genes were increased; however, the levels of most, with the exception of Scot and Cpt‑1b, were suppressed after 24 h. Protein degradation and a decrease in protein synthesis were observed after 5 h of starvation, followed by autophagy with morphological atrophy at 24 h. Supplementation with specific substrates, with the exception of leucine, such as glucose, glutamine, lactic acid or α‑ketoglutarate, attenuated the suppression of mitochondrial activity, and altered gene expression, protein degradation and myotube atrophy in starved myotubes. Furthermore, the decrease in intracellular ATP production after 24 h of starvation was reversed by restoring glycolysis in glucose‑treated cells, and via an increase in mitochondrial respiration in cells treated with glutamine, lactic acid or α‑ketoglutarate. In conclusion, increasing the availability of glucose, glutamine, lactic acid or α‑ketoglutarate may be beneficial for countering muscle atrophy associated with inadequate nutrient intake.

Introduction

Skeletal muscles require large amounts of energy to generate the force and power needed to sustain physical activity. To maintain a high-energy state, muscle tissues store important fuel substrates, such as proteins (source of amino acids) and glycogen (source of carbohydrates) (1). Thus, an adequate supply of metabolic substrates is crucial for maintaining muscle mass and function. However, due to various physiological and environmental conditions, the supply of such substrates may be insufficient. In particular, undernutrition and starvation are among the primary causes of substrate shortage for energy production in skeletal muscles, leading to muscle weakness and atrophy, which can lead to muscular disorders, such as sarcopenia (2,3).

Various nutritional supplementation methods have been proposed as effective strategies for maintaining muscle mass and preventing muscle dysfunction and atrophy (4,5). Muscle mass largely depends on the balance between protein synthesis and degradation, regulated by cellular energy status through specific anabolic and catabolic signaling pathways (6,7). Among proteins and amino acids, leucine, a branched-chain amino acid, has piqued interest as a nutritional supplement for muscle maintenance owing to its potent ability to stimulate anabolic signals both in vitro and in vivo (79). A recent comprehensive clinical review reported that, although the evidence supporting the recommendation of leucine for increasing muscle mass and strength is low to moderate, it is the best nutrient available among several other nutrients that have been investigated (10).

In contrast, no clear recommendations are available for specific nutrients that inhibit catabolic reactions, such as muscle autophagy. When cells and tissues, particularly those with high energy demands, such as the heart and muscles, encounter an energy deficiency, they mobilize fuel substrates in response to the cellular environment, shift the substrate preference to that available for energy production, and attempt to maintain their energy status at a safe level using these fuels (1114). However, an insufficient supply of extracellular nutrients for such an adaptive reaction activates the autophagy pathway for mobilizing glucose, amino acids, and fatty acids from different organelles for use as a source of energy (15). Therefore, ensuring a sufficient supply of certain nutrients that can be efficiently utilized by muscle tissue may be a viable strategy to prevent muscle catabolism.

Myotubes derived from mouse C2C12 myoblast cell lines are commonly used as a model system for studying skeletal muscle biology. Although the metabolic profile of C2C12-derived myotubes is not identical to that of skeletal muscle, C2C12 myotubes exhibit characteristics similar to those of skeletal muscle in terms of nutrient metabolism (16). Therefore, this cell line has been used in studies investigating muscle metabolism and its alterations (1719). In addition, when C2C12 myotubes are in a fasting state, they not only display atrophic morphology but also exhibit specific metabolic profiles observed in atrophic muscles, characterized by accelerated protein breakdown through the activation of two major protein degradation systems: the ubiquitin-proteasome and autophagy-lysosome systems (20,21). Several nutrient substrates have been examined for their potential to inhibit myotube atrophy induced by starvation. However, the starvation conditions varied across studies, leading to inconsistent results, even when the same substrates were used.

Therefore, in this study, we aimed to compare the metabolic features of different substrates and their efficiency as energy fuels in C2C12 muscle cells under fasting conditions. The cells were starved by incubating them in a medium devoid of the main nutrients, and their metabolic profile, including anabolic and catabolic signaling, was analyzed in response to treatment with each nutrient substrate.

Materials and methods

Materials

D-glucose (Glc), L-glutamine (Gln), L-glutamic acid (Glu), L-leucine (Leu), L-valine (Val), β-hydroxy butyric acid (βOHB), and FA-free bovine serum albumin (BSA) were purchased from FUJIFILM Wako Pure Chemicals (Osaka, Japan). Palmitic acid (PA), oleic acid (OA), and 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazoli-umbromide (MTT) were purchased from Nacalai Tesque (Kyoto, Japan). Sodium lactate (LA) and dimethyl α-ketoglutarate (αKG; an esterified form of α-ketoglutarate) were purchased from Otsuka Pharmaceutical (Tokyo, Japan) and Combi-Blocks (San Diego, CA, USA), respectively. All chemicals, except PA and OA, were dissolved in deionized distilled water.

Preparation of fatty acid complex

The cells were treated with fatty acids (FAs) using a previously described method, wherein the fatty acids were individually complexed with BSA in phosphate-buffered saline (PBS) (22). Briefly, FAs (PA or OA) were added to 100 mM NaOH solution and dissolved in a heat-block at 75°C for 30 min to obtain the FA solution. The prepared FA solution was added to 10% (w/v) FA-free BSA in PBS at a ratio of 1:9 (v/v) to obtain a 10 mM FA solution. This solution was added to the medium at a final concentration of 0.1 or 0.2 mM FA. A mixture of 100 mM NaOH and 10% BSA/PBS (1:9) was used as the vehicle control. Each prepared solution was heated up to 55°C before being added to the cells.

Cell culture and treatment

Mouse C2C12 myoblast cell line (RCB0987) was purchased from the RIKEN BioResource Research Center (Tsukuba, Japan). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 5.5 mM glucose (041-29775; FUJIFILM Wako Pure Chemicals) supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere with 5% CO2. To induce differentiation of myoblasts into myotubes, C2C12 cells at 80% confluency were maintained in the differentiation medium (DMEM containing 2% horse serum; Thermo Fisher Scientific, Tokyo, Japan) for 6 days. For starvation, the differentiation medium was replaced with ‘starvation medium’-DMEM lacking glucose, glutamine, and pyruvate (A14430; Thermo Fisher Scientific)- and the cells were incubated for the specified durations before harvesting. The control cells were incubated in regular DMEM without serum for the same durations. For some experiments, a specific nutrient was added to the starvation medium at concentrations within the medium to high physiological range, which are typically used in cell experiments. The concentrations of each nutrient used in this study are shown in Table I.

Table I.

Type and concentration of substrates added to the cells.

Table I.

Type and concentration of substrates added to the cells.

TypeSubstrate (abbreviation)Concentration in medium
MonosaccharideGlucose (Glc)5.5 mM
Amino acidGlutamine (Gln)2.0 mM
Glutamic acid (Glu)0.2 mM
Leucine (Leu)0.2 mM
Valine (Val)0.2 mM
Fatty acidPalmitic acid (PA)0.1 and 0.2 mM
Oleic acid (OA)0.1 and 0.2 mM
Lactic acidLactate (LA)10 mM
Ketoneβ-hydroxy butyric acid (βOHB)0.5 mM
TCA cycle intermediateα-ketoglutarate (αKG)2.0 mM
MTT assay

Cell viability was assessed using the MTT assay. The tetrazolium salt MTT is metabolized to insoluble purple formazan crystals in the mitochondria, which can be quantified upon solubilization using a spectrophotometer. The incubation medium was replaced with a medium containing MTT (0.5 mg/ml) 3 h before analysis. After the 3-h incubation period, the medium was replaced with dimethyl sulfoxide (250 µl/well in a 24-well plate) to dissolve the formazan crystals. The absorbance was measured at 570 nm using a microplate reader (Multiskan FC; Thermo Fisher Scientific JP, Tokyo, Japan).

Reverse transcription-quantitative PCR (RT-qPCR)

Total RNA was isolated from cells using the RNAiso Plus reagent (TAKARA BIO, Shiga, Japan), and first-strand cDNA was synthesized using the ReverTra Ace qPCR RT Master Mix (TOYOBO, Osaka, Japan), according to the manufacturer's instructions. qPCR was performed using TB Green Premix Ex Taq II (TAKARA BIO) in 10-µl reactions on a StepOne Plus Real-Time PCR System (Thermo Fisher Scientific). The qPCR cycling conditions were as follows: One cycle of 30 sec at 95°C, followed by 40 cycles of 5 sec at 95°C, and finally, one cycle of 30 sec at 60°C. Gene expression was normalized to that of a standard housekeeping gene (β-actin) and analyzed with the 2−ΔΔCq method (23). Experiments were performed in duplicate. The primer sequences are listed in Table SI.

Western blotting

Cells were washed and lysed with 50 µl of lysis buffer [1% Triton X-100, 0.45% sodium pyrophosphate, 100 mM NaF, 2 mM Na3VO4, 50 mM HEPES (pH 8.0), 147 mM NaCl, 1 mM EDTA, and a protease inhibitor mixture (cOmplete; Sigma-Aldrich, Tokyo, Japan)]. Then, the lysed cells were centrifuged at 13,000 × g, 4°C, for 15 min to obtain the supernatant, which was used as the cell lysate. Equal amounts of cell lysate proteins were loaded (10 µg per lane) onto a 15% acrylamide gel for microtubule-associated protein light-chain 3 (LC3) and onto a 10% acrylamide gel for other proteins, separated by SDS-PAGE electrophoresis, and transferred onto PVDF membranes (Hybond-P; GE Healthcare Life Science, Tokyo, Japan). The membranes were blocked with Blocking One-P (Nacalai Tesque) for 60 min at room temperature (22–24°C) and then incubated overnight (16–18 h) at 4°C with primary antibodies against each of the following proteins: LC3 (#2775), 70-kDa ribosomal protein S6 kinase (p70S6K; #9202), phosphorylated-p70S6K (#9205), AMP-activated protein kinase (AMPK; #2532), and phosphorylated-AMPK (#2535), all purchased from Cell Signaling (Danvers, MA, USA), or β-actin (#sc47778; Santa Cruz Biotechnology, Dallas, TX, USA). After washing with PBS containing 0.1% Tween 20 (TBS-T), the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature (22–24°C). Specific proteins were detected by chemiluminescence using the ECL Select Western Blotting Detection Reagent (GE Healthcare). Images were captured and quantified using the iBright Imaging System (Thermo Fisher Scientific JP).

Fluorescence imaging of myotubes

Differentiated C2C12 cells were fixed and permeabilized for 10 min at room temperature (22–24°C) using 1% Triton-X containing 4% paraformaldehyde in PBS. Then, the cells were incubated with MF-20 anti-MHC antibody (1:100; Hybridoma Bank, Iowa, IA, USA) for 90 min at room temperature, washed with PBS-T, and incubated for 1 h with fluorescein isothiocyanate-conjugated anti-mouse IgG (1:500; #115-095-062; Jackson ImmunoResearch, West Grove, PA, USA). For each condition, representative images of the cells were captured using a 10× objective lens on a fluorescence microscope (BZ-X700; Keyence, Osaka, Japan).

Analysis of ATP production and glycolytic capacity

Cellular ATP production and glycolytic capacity were evaluated using the Glycolysis/OXPHOS Assay Kit (G270; Dojindo, Kumamoto, Japan), following the manufacturer's instructions. Differentiated myotubes were incubated without or with 2.5 µM oligomycin (an inhibitor of the mitochondrial respiratory chain) in a 96-well culture plate for 3 h. Then, ATP working solution was added to each well to assess ATP production. The plate was incubated for 10 min at 25°C, and relative ATP content was measured as luminescence intensity, using a multimode plate reader (EnSpire, Perkin Elmer Japan, Yokohama, Japan).

Statistical analysis

Data are expressed as the mean ± standard error of the mean. All statistical analyses were performed using the IBM SPSS Statistics for Windows (version 29; IBM Japan, Tokyo, Japan). The unpaired Student's t-test was used to identify significant differences between two groups, and one-way analysis of variance followed by Tukey's post-hoc test was performed to determine differences among three or more groups. P<0.05 was considered to indicate a statistically significant difference.

Results

Nutrient starvation suppresses mitochondrial activity in muscle cells

Mitochondrial dehydrogenases reduce MTT to formazan; thus, formazan production depends on the redox activity of the cell and reflects mitochondrial function (24). Consequently, the amount of formazan produced can be interpreted as an indicator of mitochondrial activity and can also be used to assess cell viability. In this study, the mitochondrial activity of C2C12 myotubes was suppressed by incubation in the starvation medium in a time-dependent manner (Fig. 1A). After 3, 8, and 24 h of starvation, the mitochondrial activity in myotubes decreased to approximately 60, 44, and 7%, respectively, when compared with that in untreated cells. The decrease in cell viability after 5 h of starvation was restored to levels comparable to those of control cells by replacing the medium with regular DMEM for 3 h (Fig. 1B). This indicates that short-term starvation of up to 5 h causes temporary suppression of mitochondrial activity rather than irreversible cell damage. In contrast, the decrease in cell viability after 8 h of starvation was not fully recovered by replacing the medium with regular DMEM (Fig. 1B). This irreversible decline in mitochondrial activity became more pronounced with longer starvation times (Fig. 1B), suggesting a transition from reversible suppression of mitochondrial respiration to irreversible cell damage due to prolonged starvation.

Nutrient starvation directly affects the expression of genes related to substrate metabolism in muscle cells

To evaluate the cellular metabolic response to nutrient starvation, we examined the expression levels of key metabolic genes using RT-qPCR. The names and roles of these genes are listed in Table SI. After 1 h of starvation, none of the genes tested showed a significant change in their expression levels (Fig. 2A). After 5 h of starvation, the gene expression of hexokinase 2 (Hk) was suppressed, whereas that of several genes involved in the uptake and degradation of fuel substrates, such as succinate-CoA ligase, subunit β (Sucla2), cluster of differentiation 36 (Cd36), medium-chain acyl-CoA dehydrogenase (Mcad), branched chain α-keto acid dehydrogenase E1α (Bckdha), and succinyl CoA 3-oxoacid CoA transferase (Scot), increased (Fig. 2B). In contrast, the expression of most metabolic genes was suppressed after 24 h of starvation, with the exception of Scot and carnitine palmitoyl transferase 1-b (Cpt1b), the latter showing a notable increase in expression (Fig. 2C).

Nutrient starvation regulates signaling pathways involved in protein metabolism in muscle cells

The balance between protein degradation and synthesis is crucial for maintaining muscle mass and is regulated by the energy status of muscle tissue. Therefore, we investigated alterations in protein metabolism. After 1 h of starvation, the expression levels of atrogin-1 (Atg1) and muscle ring finger 1 (Murf1), which contribute to muscle proteolysis, remained unchanged. However, after 5 h of starvation, the expression levels of these genes increased significantly, accompanied by a trend toward AMPK activation (P=0.07) (Fig. 3A and B), whereas the LC3II/LC3I ratio, a representative autophagy marker, showed no change (Fig. 3B).

After 24 h of starvation, Atg1 and Murf1 expression remained elevated when compared with that in controls; however, the difference was less pronounced than that after 5 h of starvation (Fig. 3A). In contrast, the LC3II/LC3I ratio increased significantly, accompanied by a marked increase in AMPK activity (Fig. 3C). Regarding protein synthesis, the activity of p70S6K, which enhances the protein synthesis pathway, was significantly suppressed after both 5 and 24 h of starvation (Fig. 3B and C). In addition, the protein levels of AMPK, LC3, and p70S6K decreased after 24 h of starvation. When cultured cells are deprived of serum, a selective proteolytic pathway is activated for specific proteins, which applies to approximately 30% of cytosolic proteins (25,26). Therefore, these proteins may have been partially degraded by this pathway.

Glc, Gln, LA, and αKG alleviated mitochondrial inactivity and alteration of metabolic gene expression in starved muscle cells

Next, we evaluated whether any of the nutrient substrates could improve the metabolic disturbances induced by nutrient starvation. MTT assay was utilized to assess the toxic effects of each nutrient at the concentrations used on mitochondrial function in myotubes maintained in a differentiation medium. PA treatment significantly impacted mitochondrial activity after 24 h of incubation (Fig. 4A); therefore, we excluded PA from further studies.

Glc replacement notably recovered the decrease in mitochondrial activity induced by 5 h of starvation, as expected. Starvation-induced metabolic inactivity in mitochondria was also attenuated by adding Gln, LA, or αKG to the starvation medium. However, other substrates did not achieve similar improvements at the tested concentrations (Fig. 4B). Even after 24 h of starvation, which caused suppression of redox activity to less than 5% of that of control cells, the addition of each of these four substrates (Glc, Gln, LA, or αKG) alleviated the decline in mitochondrial activity to varying extents (Fig. 4C).

We also examined the expression levels of genes whose expression changed after the cells were starved for 24 h. All four substrates tested (Glc, Gln, LA, or αKG) attenuated the decrease in the expression of the following genes in starved cells: Glucose transporter 4 (Glut4), oxoglutarate dehydrogenase (Ogdh), glutamate dehydrogenase 1 (Glud1), branched-chain amino transaminase 2 (Bcat2), Bckdha, lactate dehydrogenase (Ldh), and monocarboxylic acid transporter 1 (Mct1) (Fig. 5). Additionally, LA or αKG attenuated fasting-induced decrease in the expression of pyruvate kinase (Pk) and citrate synthase (Cs). Glc, Gln, or αKG attenuated that of Mcad, while they suppressed the fasting-induced increase in Cpt1b expression (Fig. 5).

Glc, Gln, LA, and αKG inhibit protein degradation and promote protein synthesis in starved muscle cells, thereby alleviating myotube atrophy

We examined the effects of selected nutrients, including βOHB, which generates acetoacetic acid as a substrate for SCOT, and Leu, as a major activator of anabolic signaling, to compare anabolic and catabolic signals. The expression of genes related to the ubiquitin-proteasome system, which peaked in fasted cells after 5 h of starvation, was suppressed upon treatment with Glc, Gln, or αKG (for Atg1), and with Gln, LA, or αKG (for Murf-1) (Fig. 6A). The increase in AMPK activity after 24 h of starvation was significantly inhibited by the administration of Glc, Gln, LA, or αKG, but not by that of βOHB or Leu (Fig. 6B). After 24 h of starvation, the enhancement of autophagy, as assessed by the LC3II/LC3I ratio, was inhibited by Glc, LA, or αKG treatment, while the inhibition of protein synthesis, as assessed by phosphorylation of p70S6K, was restored by treatment with all the tested substrates, except βOHB (Fig. 6B).

Additionally, we evaluated the effect of nutrients, which restored the starvation-induced inhibition of p70S6K phosphorylation on myotube morphology (Fig. 6C). Generally, atrophy occurs when protein breakdown exceeds protein synthesis in muscle cells. Consistent with the results for anabolic and catabolic signaling in the previous section, the incubation of cells in the starvation medium for 24 h led to severe myotube atrophy. Notably, treatment with Glc not only prevented fasting-induced atrophy but also promoted hypertrophic changes in myotubes. Treatment with Gln, LA, or αKG also prevented myotube atrophy but to a lesser extent than that with Glc. Unexpectedly, Leu showed no protective effects against myotube atrophy caused by nutrient starvation.

Gln, LA, and αKG enhance ATP production in starved muscle cells via oxidative phosphorylation

Finally, we investigated the metabolic pathways through which each nutrient contributes to cellular energy production. In the regular differentiation medium, ATP production in myotubes primarily relied on glycolysis. After 24 h of starvation, glycolytic ATP production significantly decreased, leading to a reduction in total ATP production; however, ATP production by oxidative phosphorylation (OxPhos) increased (Fig. 7). This indicates that nutritional inadequacy triggers a metabolic shift in muscle cells. The starvation-induced decrease in intracellular ATP production was fully restored by the addition of Glc, Gln, LA, or αKG to the starvation medium, resulting in higher intracellular ATP production when compared with that in control cells. This restoration of ATP production was primarily driven by the recovery of glycolysis in Glc-treated cells, whereas it was facilitated by an increase in OxPhos-derived ATP generation in cells treated with Gln, LA, or αKG (Fig. 7).

Discussion

In muscle tissues under starvation conditions, the rate of protein degradation exceeds the rate of protein synthesis, leading to a decrease in skeletal muscle mass. To assess muscle cell biology in atrophied muscles, myocytes derived from C2C12 cells deprived of nutrient substrates have been utilized (20,2730). However, starvation conditions varied across these studies; either saline (PBS or HEPES buffered saline) containing only inorganic salts (28,29) or containing 2% horse serum (20) was used as the starvation medium, or serum-free DMEM with (27) or without (30) Glc. We confirmed that 6 h of incubation with PBS resulted in the detachment of more than half of the cells from the bottom of the dish. In contrast, incubation with serum-free DMEM for up to 24 h had no effect on cell morphology (data not shown). Therefore, in this study, we utilized DMEM as the starvation medium, wherein the serum and main energetic nutrients are absent, following the method used by Zeidler et al (31). The authors stated that short-term starvation in such a medium was an appropriate approach for evaluating the influence of fuel substrates on cellular metabolism.

Short-term (1 h) starvation using this medium did not impact mitochondrial metabolic activity in C2C12 myotubes, as assessed by the MTT assay. Similarly, 1 h of starvation caused no changes in the expression levels of the metabolic genes that were tested. These findings, consistent with the results of a previous study (31), suggest that a 1-h starvation period is unlikely to induce adaptive changes as the presence of residual substrates within the cells prevents energy depletion. Extending the starvation period to 5 h led to a reversible decrease in mitochondrial activity and an increase in the expression of genes involved in fuel utilization, particularly Sucla2, Cd36, Mcad, Bckdha, and Scot. CD36 is a glycoprotein that facilitates FA transport into cells, and MCAD is an enzyme that catabolizes FA. Both of these play a role in FA oxidation for mitochondrial ATP production (32). Studies have shown that the expression of genes related to FA oxidation, including these two, is upregulated in skeletal muscles during starvation across several animal species (3335). During starvation, animal bodies attempt to maintain ATP production by rapidly shifting fuel substrates from glucose to lipids (13). This aligns with our findings of increased Cd36 and Mcad expression and decreased Hk2 expression, a key enzyme for glycolysis, supporting this adaptive phenomenon. Additionally, BCKDHA and SCOT metabolize branched-chain amino acids and ketone bodies, respectively, providing substrates for TCA cycle, while SUCLA2 is an enzyme involved the TCA cycle. Thus, the increased expression of these genes may represent an adaptive response to enhance intracellular substrate supply for mitochondrial ATP production.

In the present study, starvation for more than 8 h led to partial irreversible cellular damage. Prolonged starvation (24 h) suppressed the expression of almost all genes tested, which contrasts the results of short-term (5 h) starvation. Consistently, studies focusing on rodent muscles have reported that the expression of genes involved in the catabolic pathway, such as glycolytic flux and mitochondrial respiration, was suppressed by prolonged starvation, and this suppression was enhanced with an increase in starvation duration (36,37). In contrast, Cpt-1 expression significantly increased after 24 h starvation. These results align with those obtained in studies with C. elegans (38,39), which reported that the expression of genes associated with catabolic pathways, including the proteasome, OxPhos, and the tricarboxylic acid (TCA) cycle, was suppressed in C. elegans fasted for 16 h, while that of Cpt-1 was markedly elevated. In these studies, survival rates during fasting reduced in the Cpt-1 knockout individuals, suggesting that the elevation of Cpt-1 expression may be a crucial biological response to endure prolonged fasting. In the present study, the expression of Scot, a key enzyme in ketone metabolism, remained elevated even after 24 h of starvation. Nevertheless, in this study, a ketone body, βOHB, could not ameliorate starvation-induced myotube atrophy. Few studies have examined the changes in Scot expression in starved muscles, but one study reported its upregulation in chicken sartorius muscle after 24 h of fasting (40). Recently ketone bodies have been reported to induce a quiescent state of muscle cells during starvation to enhance their resilience (41). An increase in Scot expression may play a role in ketone signaling to prevent muscle cells from starvation-induced damage.

Regarding the effects of individual nutrients on starvation, among those tested in this study, the addition of Glc, Gln, LA, or αKG mitigated the decrease in metabolic activity observed in myotubes subjected to 5 h of starvation. Supplementation with each of these four nutrients attenuated metabolic alterations, such as the decrease in mitochondrial activity and changes in metabolic gene expression to varying degrees, even after 24 h of starvation. In contrast, OA administration did not improve cellular metabolism under starvation conditions, despite a significant increase in the expression of Cpt-1, a key molecule for transporting long-chain FAs into the mitochondria, after prolonged nutritional deprivation. In the OA supplementation experiments, starvation-induced metabolic changes were not observed (Fig. 4B), probably due to the addition of albumin as a vehicle control in the starvation medium, which may have masked any potential effects of starvation or OA treatment.

The mechanism by which certain nutrients, such as Glc, Gln, LA, and αKG, improve metabolic disturbance in muscle cells may involve AMPK, a crucial sensor of energy status in skeletal muscles. In the present study, ATP content decreased in 24-h-starved cells, leading to significant activation of AMPK, while administration of Glc, Gln, LA, or αKG, but not βOHB and Leu, suppressed this starvation-induced activation of AMPK. Activated AMPK inhibits mTOR activity via phosphorylation of the adaptor protein, Raptor (42), resulting in decreased protein synthesis via inhibition of the mTOR/p70S6K pathway (43) and increased proteolysis via autophagy (44,45), ultimately leading to muscle fiber atrophy. In the present study, Glc, Gln, LA, or αKG inhibited AMPK activation, reversing the reduction in protein synthesis and preventing autophagy, thereby ameliorating the histological atrophy of myotubes caused by starvation. These results suggest that Glc, Gln, LA, and αKG contribute to ATP production, which inhibits AMPK activation, thereby preventing muscle atrophy. Additionally, Glu and its metabolite αKG have been reported to directly activate mTORC1, promoting protein synthesis (46), which may contribute to their beneficial effects on muscle cell atrophy. On the other hand, Leu is also a potent stimulator of mTORC1 (47,48) and is widely recognized as a crucial nutritional factor for preventing muscle atrophy (49,50). Leu administration could restore experimentally induced atrophy in C2C12 myotubes (51,52). However, in the present study, although Leu enhanced mTOR-S6K signaling, it was unable to ameliorate the metabolic abnormalities and histological atrophy induced by starvation. Thus, an adequate supply of ATP to muscle cells may be essential for leveraging the potential of Leu as a protein synthesis stimulator to prevent muscle atrophy.

In the present study, treatment with Glc not only prevented starvation-induced atrophy but also promoted hypertrophic changes in myotubes. Consistent with this, Nakai et al (30) reported that addition of Glc markedly increased the phosphorylation of p70S6K only in starved C2C12 myotubes and that starvation-induced autophagy accounts for the activation of p70S6K by adding Glc. Gln, LA, and αKG, also improve atrophic changes in nutrient-deficient muscle cells. These findings are consistent with those of several studies demonstrating that these nutrients prevent muscle atrophy or promote muscle hypertrophy both in vitro and in vivo (5357). These studies reported as the underlying mechanisms that αKG as well as Gln directly activated the mTOR pathway (53), or that αKG inhibited proline hydroxylase 3 to stimulate β2 adrenergic receptor (54). Regarding LA, Ohno et al (57) proposed that the activation of GPR81 (with LA acting as a ligand)-ERK signaling in muscle cells is involved in the mechanistic pathway. Thus, Gln, LA, or αKG may function not only as energy fuels but also as signaling molecules that help to prevent muscle atrophy.

To maintain energy supply, energy-consuming organs such as heart and muscles can switch between and adapt to energy substrates in response to external or internal environmental factors. Glucose is the most preferred energy substrate for skeletal muscles and when a sufficient amount of glucose is available after feeding, skeletal muscles increase glucose utilization and storage while reducing fatty acid oxidation. In contrast, when nutrient supply to the muscles is interrupted, such as during starvation or sleep, the rate of fatty acid oxidation rapidly increases (13,58). In addition, several nutrients other than fatty acids, such as lactate and glutamine are also gaining attention as alternative energy sources for muscles during fasting. One study using intravenous infusions of 13C-labelled nutrients showed that lactate contributes significantly to the TCA cycle carbon in muscle tissues of fasted mice, suggesting it as a primary source for maintaining muscle ATP levels (59). Additionally, Li et al (60) reported that in the muscles of fasted mice, glutaminolysis was upregulated before an increase in FA oxidation, indicating the crucial role of a substrate shift from glucose to glutamine in sustaining muscle energy supply under starvation condition. Metabolic shifting is generally believed to be regulated by neurogenic and serum factors, such as hormones. However, in the present study, we observed a similar phenomenon in cultured muscle cells-ATP production shifted from glycolysis to OxPhos when nutrient supply was interrupted. Moreover, LA, Gln, and its metabolite αKG effectively supported cellular ATP production through OxPhos. This suggests that even in the absence of neural and serum regulators, muscle cells can switch their metabolism based on the available substrates.

In conclusion, we examined the metabolic characteristics of various nutritional substrates and their efficiency in C2C12 muscle cells under starvation conditions. Our findings revealed that certain nutrients, such as Gln, LA, and αKG, help to improve metabolic imbalances and counteract atrophic changes caused by energy deprivation in muscle cells. To the best of our knowledge, this is the first study to compare the effects of multiple nutrients on metabolic changes in muscle cells experiencing energy substrate deficiency. Our findings could potentially be translated into an effective nutritional strategy to prevent muscle atrophy.

Supplementary Material

Supporting Data

Acknowledgements

Not applicable.

Funding

This work was supported by JSPS KAKENHI (grant nos. JP23K20665 and JP24K22267) from the Japan Society for the Promotion of Science, and partially supported by Morinaga Seika Co., Tokyo, Japan.

Availability of data and materials

The data generated in the present study may be requested from the corresponding author.

Authors' contributions

MI, MM and KI designed and conceived the study, analyzed the results and drafted the manuscript. MI, MM and MT conducted the experiments and collected the data. MK contributed to the study design and supervised the experiments. KI supervised the entire project and obtained the research grants. MI and KI confirm the authenticity of all the raw data. All authors read and approved the final version of the manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Glossary

Abbreviations

Abbreviations:

AMPK

AMP-activated protein kinase

ATG1

atrogin-1

Glc

glucose

Gln

glutamine

Glu

glutamic acid

αKG

α-ketoglutarate

LA

lactate

LC3

microtubule-associated protein light-chain 3

Leu

leucine

Murf1

muscle ring finger 1

OA

oleic acid

βOHB

β-hydroxy butyric acid

PA

palmitic acid

p70S6K

70-kDa ribosomal protein S6 kinase

Val

valine

References

1 

Frontera WR and Ochala J: Skeletal muscle: A brief review of structure and function. Calcif Tissue Int. 96:183–195. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Sieber CC: Malnutrition and sarcopenia. Aging Clin Exp Res. 31:793–798. 2019. View Article : Google Scholar : PubMed/NCBI

3 

Yuan S and Larsson SC: Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 144:1555332023. View Article : Google Scholar : PubMed/NCBI

4 

Owens DJ: Nutritional support to counteract muscle atrophy. Adv Exp Med Biol. 1088:483–495. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Wang Y, Liu Q, Quan H, Kang SG, Huang K and Tong T: Nutraceuticals in the prevention and treatment of the muscle atrophy. Nutrients. 13:19142021. View Article : Google Scholar : PubMed/NCBI

6 

Hoffman EP and Nader GA: Balancing muscle hypertrophy and atrophy. Nat Med. 10:584–585. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Sartori R, Romanello V and Sandri M: Mechanisms of muscle atrophy and hypertrophy: Implications in health and disease. Nat Commun. 12:3302021. View Article : Google Scholar : PubMed/NCBI

8 

Carbone JW, Margolis LM, McClung JP, Cao JJ, Murphy NE, Sauter ER, Combs GF Jr, Young AJ and Pasiakos SM: Effects of energy deficit, dietary protein, and feeding on intracellular regulators of skeletal muscle proteolysis. FASEB J. 27:5104–5111. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Pasiakos SM, Margolis LM and Orr JS: Optimized dietary strategies to protect skeletal muscle mass during periods of unavoidable energy deficit. FASEB J. 29:1136–1142. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Gielen E, Beckwée D, Delaere A, De Breucker S, Vandewoude M and Bautmans I; Sarcopenia Guidelines Development Group of the Belgian Society of Gerontology Geriatrics (BSGG), : Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: An umbrella review of systematic reviews and meta-analyses. Nutr Rev. 79:121–147. 2021. View Article : Google Scholar : PubMed/NCBI

11 

Bertero E and Maack C: Metabolic remodelling in heart failure. Nat Rev Cardiol. 15:457–470. 2018. View Article : Google Scholar : PubMed/NCBI

12 

Lopaschuk GD, Karwi QG, Tian R, Wende AR and Abel ED: Cardiac energy metabolism in heart failure. Circ Res. 128:1487–1513. 2021. View Article : Google Scholar : PubMed/NCBI

13 

Olson B, Marks DL and Grossberg AJ: Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia. J Cachexia Sarcopenia Muscle. 11:1429–1446. 2020. View Article : Google Scholar : PubMed/NCBI

14 

Mengeste AM, Rustan AC and Lund J: Skeletal muscle energy metabolism in obesity. Obesity (Silver Spring). 29:1582–1595. 2021. View Article : Google Scholar : PubMed/NCBI

15 

Boya P, Reggiori F and Codogno P: Emerging regulation and functions of autophagy. Nat Cell Biol. 15:713–720. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Deshmukh AS, Murgia M, Nagaraj N, Treebak JT, Cox J and Mann M: Deep proteomics of mouse skeletal muscle enables quantitation of protein isoforms, metabolic pathways, and transcription factors. Mol Cell Proteomics. 14:841–853. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Pavlovic K, Krako Jakovljevic N, Isakovic AM, Ivanovic T, Markovic I and Lalic NM: Therapeutic vs suprapharmacological metformin concentrations: Different effects on energy metabolism and mitochondrial function in skeletal muscle cells in vitro. Front Pharmacol. 13:9303082022. View Article : Google Scholar : PubMed/NCBI

18 

Akhtar J, Han Y, Han S, Lin W, Cao C, Ge R, Babarinde IA, Jia Q, Yuan Y, Chen G, et al: Bistable insulin response: The win-win solution for glycemic control. iScience. 25:1055612022. View Article : Google Scholar : PubMed/NCBI

19 

Yang B, Liu Y and Steinacker JM: α-Ketoglutarate stimulates cell growth through the improvement of glucose and glutamine metabolism in C2C12 cell culture. Front Nutr. 10:11452362023. View Article : Google Scholar : PubMed/NCBI

20 

Desgeorges MM, Freyssenet D, Chanon S, Castells J, Pugnière P, Béchet D, Peinnequin A, Devillard X and Defour A: Post-transcriptional regulation of autophagy in C2C12 myotubes following starvation and nutrient restoration. Int J Biochem Cell Biol. 54:208–216. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Li F, Li X, Peng X, Sun L, Jia S, Wang P, Ma S, Zhao H, Yu Q and Huo H: Ginsenoside Rg1 prevents starvation-induced muscle protein degradation via regulation of AKT/mTOR/FoxO signaling in C2C12 myotubes. Exp Ther Med. 14:1241–1247. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Matsuba I, Fujita R and Iida K: Palmitic acid inhibits myogenic activity and expression of myosin heavy chain MHC IIb in muscle cells through phosphorylation-dependent MyoD inactivation. Int J Mol Sci. 24:58472023. View Article : Google Scholar : PubMed/NCBI

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Musser DA and Oseroff AR: The use of tetrazolium salts to determine sites of damage to the mitochondrial electron transport chain in intact cells following in vitro photodynamic therapy with photofrin II. Photochem Photobiol. 59:621–626. 1994. View Article : Google Scholar : PubMed/NCBI

25 

Dice JF: Selective degradation of cytosolic proteins by lysosomes. Ann N Y Acad Sci. 674:58–64. 1992. View Article : Google Scholar : PubMed/NCBI

26 

Dice JF: Molecular determinants of protein half-lives in eukaryotic cells. FASEB J. 1:349–357. 1987. View Article : Google Scholar : PubMed/NCBI

27 

Duan Y, Li F, Guo Q, Wang W, Zhang L, Wen C, Chen X and Yin Y: β-Hydroxy-β-methyl butyrate is more potent than leucine in inhibiting starvation-induced protein degradation in C2C12 myotubes. J Agric Food Chem. 66:170–176. 2018. View Article : Google Scholar : PubMed/NCBI

28 

Caldow MK, Ham DJ, Trieu J, Chung JD, Lynch GS and Koopman R: Glycine protects muscle cells from wasting in vitro via mTORC1 signaling. Front Nutr. 6:1722019. View Article : Google Scholar : PubMed/NCBI

29 

Zhang H, Wang F, Pang X, Zhou Y, Li S, Li W, Zhang P and Chen X: Decreased expression of H19/miR-675 ameliorates muscle atrophy by regulating the IGF1R/Akt/FoxO signaling pathway. Mol Med. 29:782023. View Article : Google Scholar : PubMed/NCBI

30 

Nakai N, Kitai S, Iida N, Inoue S and Higashida K: Autophagy under glucose starvation enhances protein translation initiation in response to re-addition of glucose in C2C12 myotubes. FEBS Open Bio. 10:2149–2156. 2020. View Article : Google Scholar : PubMed/NCBI

31 

Zeidler JD, Fernandes-Siqueira LO, Carvalho AS, Cararo-Lopes E, Dias MH, Ketzer LA, Galina A and Da Poian AT: Short-term starvation is a strategy to unravel the cellular capacity of oxidizing specific exogenous/endogenous substrates in mitochondria. J Biol Chem. 292:14176–14187. 2017. View Article : Google Scholar : PubMed/NCBI

32 

de Lange P, Moreno M, Silvestri E, Lombardi A, Goglia F and Lanni A: Fuel economy in food-deprived skeletal muscle: Signaling pathways and regulatory mechanisms. FASEB J. 21:3431–3441. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Samec S, Seydoux J, Russell AP, Montani JP and Dulloo AG: Skeletal muscle heterogeneity in fasting-induced upregulation of genes encoding UCP2, UCP3, PPARgamma and key enzymes of lipid oxidation. Pflugers Arch. 445:80–86. 2002. View Article : Google Scholar : PubMed/NCBI

34 

Frier BC, Jacobs RL and Wright DC: Interactions between the consumption of a high-fat diet and fasting in the regulation of fatty acid oxidation enzyme gene expression: An evaluation of potential mechanisms. Am J Physiol Regul Integr Comp Physiol. 300:R212–R221. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Saneyasu T, Kimura S, Kitashiro A, Tsuchii N, Tsuchihashi T, Inui M, Honda K and Kamisoyama H: Differential regulation of the expression of lipid metabolism-related genes with skeletal muscle type in growing chickens. Comp Biochem Physiol B Biochem Mol Biol. 189:1–5. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Jagoe RT, Lecker SH, Gomes M and Goldberg AL: Patterns of gene expression in atrophying skeletal muscles: Response to food deprivation. FASEB J. 16:1697–1712. 2002. View Article : Google Scholar : PubMed/NCBI

37 

Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE and Goldberg AL: Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18:39–51. 2004. View Article : Google Scholar : PubMed/NCBI

38 

Harvald EB, Sprenger RR, Dall KB, Ejsing CS, Nielsen R, Mandrup S, Murillo AB, Larance M, Gartner A, Lamond AI and Færgeman NJ: Multi-omics analyses of starvation responses reveal a central role for lipoprotein metabolism in acute starvation survival in C. elegans. Cell Syst. 5:38–52.e4. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Dall KB, Havelund JF, Harvald EB, Witting M and Faergeman NJ: HLH-30-dependent rewiring of metabolism during starvation in C. elegans. Aging Cell. 20:e133422021. View Article : Google Scholar : PubMed/NCBI

40 

Skiba-Cassy S, Collin A, Chartrin P, Médale F, Simon J, Duclos MJ and Tesseraud S: Chicken liver and muscle carnitine palmitoyltransferase 1: Nutritional regulation of messengers. Comp Biochem Physiol B Biochem Mol Biol. 147:278–287. 2007. View Article : Google Scholar : PubMed/NCBI

41 

Benjamin DI, Both P, Benjamin JS, Nutter CW, Tan JH, Kang J, Machado LA, Klein JDD, de Morree A, Kim S, et al: Fasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling. Cell Metab. 34:902–918.e6. 2022. View Article : Google Scholar : PubMed/NCBI

42 

Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE and Shaw RJ: AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 30:214–226. 2008. View Article : Google Scholar : PubMed/NCBI

43 

Tavares MR, Pavan IC, Amaral CL, Meneguello L, Luchessi AD and Simabuco FM: The S6K protein family in health and disease. Life Sci. 131:1–10. 2015. View Article : Google Scholar : PubMed/NCBI

44 

Diaz-Troya S, Pérez-Pérez ME, Florencio FJ and Crespo JL: The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy. 4:851–865. 2008. View Article : Google Scholar : PubMed/NCBI

45 

Mugume Y, Kazibwe Z and Bassham DC: Target of rapamycin in control of autophagy: Puppet master and signal integrator. Int J Mol Sci. 21:82592020. View Article : Google Scholar : PubMed/NCBI

46 

Durán RV, Oppliger W, Robitaille AM, Heiserich L, Skendaj R, Gottlieb E and Hall MN: Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell. 47:349–358. 2012. View Article : Google Scholar : PubMed/NCBI

47 

Dodd KM and Tee AR: Leucine and mTORC1: A complex relationship. Am J Physiol Endocrinol Metab. 302:E1329–E1342. 2012. View Article : Google Scholar : PubMed/NCBI

48 

Han JM, Jeong SJ, Park MC, Kim G, Kwon NH, Kim HK, Ha SH, Ryu SH and Kim S: Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell. 149:410–424. 2012. View Article : Google Scholar : PubMed/NCBI

49 

Leenders M and van Loon LJ: Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes. Nutr Rev. 69:675–689. 2011. View Article : Google Scholar : PubMed/NCBI

50 

Ham DJ, Caldow MK, Lynch GS and Koopman R: Leucine as a treatment for muscle wasting: A critical review. Clin Nutr. 33:937–945. 2014. View Article : Google Scholar : PubMed/NCBI

51 

Mobley CB, Fox CD, Ferguson BS, Amin RH, Dalbo VJ, Baier S, Rathmacher JA, Wilson JM and Roberts MD: L-leucine, beta-hydroxy-beta-methylbutyric acid (HMB) and creatine monohydrate prevent myostatin-induced Akirin-1/Mighty mRNA down-regulation and myotube atrophy. J Int Soc Sports Nutr. 11:382014. View Article : Google Scholar : PubMed/NCBI

52 

Oelkrug C, Horn K, Makert GR and Schubert A: Novel in vitro platform to investigate myotube atrophy. Anticancer Res. 35:2085–2091. 2015.PubMed/NCBI

53 

Wang L, Yi D, Hou Y, Ding B, Li K, Li B, Zhu H, Liu Y and Wu G: Dietary supplementation with α-ketoglutarate activates mTOR signaling and enhances energy status in skeletal muscle of lipopolysaccharide-challenged piglets. J Nutr. 146:1514–1520. 2016. View Article : Google Scholar : PubMed/NCBI

54 

Cai X, Yuan Y, Liao Z, Xing K, Zhu C, Xu Y, Yu L, Wang L, Wang S, Zhu X, et al: α-Ketoglutarate prevents skeletal muscle protein degradation and muscle atrophy through PHD3/ADRB2 pathway. FASEB J. 32:488–499. 2018. View Article : Google Scholar : PubMed/NCBI

55 

Tsukamoto S, Shibasaki A, Naka A, Saito H and Iida K: Lactate promotes myoblast differentiation and myotube hypertrophy via a pathway involving MyoD in vitro and enhances muscle regeneration in vivo. Int J Mol Sci. 19:36492018. View Article : Google Scholar : PubMed/NCBI

56 

Ohno Y, Oyama A, Kaneko H, Egawa T, Yokoyama S, Sugiura T, Ohira Y, Yoshioka T and Goto K: Lactate increases myotube diameter via activation of MEK/ERK pathway in C2C12 cells. Acta Physiol (Oxf). 223:e130422018. View Article : Google Scholar : PubMed/NCBI

57 

Ohno Y, Nakatani M, Ito T, Matsui Y, Ando K, Suda Y, Ohashi K, Yokoyama S and Goto K: Activation of lactate receptor positively regulates skeletal muscle mass in mice. Physiol Res. 72:465–473. 2023. View Article : Google Scholar : PubMed/NCBI

58 

Goodpaster BH and Sparks LM: Metabolic flexibility in health and disease. Cell Metab. 25:1027–1036. 2017. View Article : Google Scholar : PubMed/NCBI

59 

Hui S, Ghergurovich JM, Morscher RJ, Jang C, Teng X, Lu W, Esparza LA, Reya T, Zhan L, Yanxiang Guo J, et al: Glucose feeds the TCA cycle via circulating lactate. Nature. 551:115–118. 2017. View Article : Google Scholar : PubMed/NCBI

60 

Li M, Wang Y, Wei X, Cai WF, Wu J, Zhu M, Wang Y, Liu YH, Xiong J, Qu Q, et al: AMPK targets PDZD8 to trigger carbon source shift from glucose to glutamine. Cell Res. 34:683–706. 2024. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

July-2025
Volume 32 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ikeda M, Matsumoto M, Tamura M, Kobayashi M and Iida K: Glucose, glutamine, lactic acid and &alpha;‑ketoglutarate restore metabolic disturbances and atrophic changes&nbsp;<br />in energy‑deprived muscle cells. Mol Med Rep 32: 197, 2025.
APA
Ikeda, M., Matsumoto, M., Tamura, M., Kobayashi, M., & Iida, K. (2025). Glucose, glutamine, lactic acid and &alpha;‑ketoglutarate restore metabolic disturbances and atrophic changes&nbsp;<br />in energy‑deprived muscle cells. Molecular Medicine Reports, 32, 197. https://doi.org/10.3892/mmr.2025.13562
MLA
Ikeda, M., Matsumoto, M., Tamura, M., Kobayashi, M., Iida, K."Glucose, glutamine, lactic acid and &alpha;‑ketoglutarate restore metabolic disturbances and atrophic changes&nbsp;<br />in energy‑deprived muscle cells". Molecular Medicine Reports 32.1 (2025): 197.
Chicago
Ikeda, M., Matsumoto, M., Tamura, M., Kobayashi, M., Iida, K."Glucose, glutamine, lactic acid and &alpha;‑ketoglutarate restore metabolic disturbances and atrophic changes&nbsp;<br />in energy‑deprived muscle cells". Molecular Medicine Reports 32, no. 1 (2025): 197. https://doi.org/10.3892/mmr.2025.13562